Uncategorized

Glaukos Corporation to Release Third Quarter 2016 Financial Results after Market Close on November 10

by Business Wire • 2016/10/13 • 0 Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release third quarter 2016 financial results after the market close on Thursday, November 10, 2016. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30 p.m. EST) on No

Full Story →

← CMS plans to overhaul Medicare’s beneficiary identification system: What you need to know

Ocular Therapeutix™ Outlines Development Strategy for Its Sustained Release Intravitreal Depots to Address Serious Retinal Diseases →

Post navigation